CG
LLY icon

Carmignac Gestion’s Eli Lilly LLY Stock Holding History

Carmignac Gestion’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-584
Closed -$537K – 117
2026
Q1 		$537K Sell
584
-1,795
-75% -$1.82M 0.01% 100
2025
Q4 		$2.56M Sell
2,379
-94,468
-98% -$90.3M 0.03% 98
2025
Q3 		$73.8M Sell
96,847
-4,479
-4% -$3.33M 1.1% 25
2025
Q2 		$79M Buy
101,326
+3,414
+3% +$2.65M 1.22% 26
2025
Q1 		$80.9M Sell
97,912
-53,558
-35% -$44.6M 1.33% 25
2024
Q4 		$117M Buy
151,470
+14,519
+11% +$12M 1.86% 17
2024
Q3 		$121M Buy
136,951
+22,558
+20% +$20.3M 2.03% 17
2024
Q2 		$104M Sell
114,393
-288,811
-72% -$231M 1.78% 15
2024
Q1 		$314M Sell
403,204
-405,994
-50% -$289M 4.96% 6
2023
Q4 		$472M Sell
809,198
-75,754
-9% -$44.2M 7.92% 1
2023
Q3 		$475M Sell
884,952
-68,070
-7% -$35.1M 8.73% 1
2023
Q2 		$447M Buy
953,022
+80,579
+9% +$33.8M 7.7% 1
2023
Q1 		$300M Buy
872,443
+250,413
+40% +$84.5M 4.99% 3
2022
Q4 		$228M Sell
622,030
-81,702
-12% -$29M 4.11% 7
2022
Q3 		$228M Sell
703,732
-85,006
-11% -$26.9M 4.89% 4
2022
Q2 		$256M Buy
788,738
+11,496
+1% +$3.45M 5.41% 3
2022
Q1 		$223M Buy
777,242
+464,204
+148% +$119M 3.6% 11
2021
Q4 		$86.5M Buy
+313,038
New +$79.4M 1.21% 23
2019
Q4 		– Sell
-1,008,978
Closed -$113M – 131
2019
Q3 		$113M Buy
+1,008,978
New +$112M 1.42% 29

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carmignac Gestion's LLY Position: Q2 2026 in Review

Carmignac Gestion sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 584 shares — an estimated $537K sold.

Carmignac Gestion first reported a position in LLY in Q3 2019 and held it in 19 quarters. The position peaked at $475M in Q3 2023. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Carmignac Gestion reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Carmignac Gestion sold 584 Eli Lilly shares in Q2 2026, an estimated $537K.
  • Carmignac Gestion first reported a position in Eli Lilly in Q3 2019 and held it in 19 quarters.
  • Carmignac Gestion's Eli Lilly position peaked at $475M in Q3 2023.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.